Special Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract/order to Immucor, Inc. Company for procurement of the following items and services: SCOPE The intent of the Amarillo Veterans Affairs Health Care System (AVAHCS) Pathology & Laboratory Medicine Service Blood Bank Department (non-automated) is to provide accurate testing and the complete antibody work-up for the cross matching of compatible blood and blood components for transfusion to the Veteran patients. Monthly deliveries of the reagents are in support of blood products for compatibly testing for in our Veteran population. This will support the mission of the VA to provide timely, accurate and appropriate laboratory services in support of life saving measures. See Attachment A for the list of quantities of reagents that are being requested for fiscal year 2024 through 2028. PERIOD OF PERFORMANCE The contract period of performance shall be a Base year (October 1, 2023, through September 31, 2024) and four (4) 1-year options. TYPE OF CONTRACT The AVAHCS intends to award a Firm Fixed Price, Blanket Purchase Agreement (BPA) contract. VENDOR RESPONSIBILITIES The Vendor shall provide, in accordance with all applicable federal, state, and local regulations, laws, and ordinances, and in accordance with the specifications outlined for accreditation certification if applicable, equipment and supplies negotiated on GSA contracts to enable AVAHCS to accurately and efficiently crossmatch blood components for patient use. The Vendor shall provide the ability to automatically ship reagents monthly to the Amarillo VAHCS. The Vendor shall provide the ability to ship reagents on an As Needed basis to the Amarillo VAHCS. The Vendor shall automatically update any changes in product numbers / item numbers / changes in vial volumes / without a modification being performed if there is no increase in pricing. Should pricing be affected due to product changes, the Vendor shall notify the Contracting Officer and Contracting Officer Representative in a timely fashion with the needed changes in the supply item/ product item in order to provide a modification and request any additional funding as needed. The vendor shall ship all the reagents to: Amarillo VA Health Care System 6010 Amarillo Blvd., West Amarillo, TX 79106 Attention: Laboratory The Vendor shall provide the facility with the most current Food and Drug Administration (FDA) approved reagents necessary for the testing of blood and blood components. All requirements and provisions defined in the specification of this solicitation will apply to any vendor, i.e., branch, division, sub-Vendor, etc. supplying parts or reagents on behalf of the Vendor. Monthly billing and test report summaries shall begin on the first day of the month and include the last day of the month. Vendor shall bill monthly in arrears and process the billing through the Government E-Invoice system. www.Tungsten-network.com Tungsten direct vendor support number is
+1 (555) 000-0000 for VA contracts. All invoices submitted through Tungsten to VA-FSC should mirror your current submission of Invoice. VA-FSC shall require the following information in compliance with the Prompt Pay Act and Business Requirements. Your Taxpayer ID number (TIN) Your Remit Address information The VA Purchase Order (PO) number Your contact information: (Personal name, Email, and Phone) Your VA Point of contact information (Personal name, Email, and Phone) The Period of Performance dates (POP Beginning and Ending) All discount information if applicable (Percent and Date Terms) Reagents used with pricing per unit No freight charges to be added to the invoice Department of Veterans Affairs Financial Service Center: Phone:
+1 (555) 000-0000 Email:
contact@example.gov AVAHCS shall not be responsible for payment of services and or supplies which are not requested in accordance with the contract. AVAHCS will NOT pay for supplies that are not clearly identified by product number on the invoice. Invoices are to be separate for Amarillo and Lubbock laboratories, but the usage of the same PO number is acceptable for billing purposes, should this be necessary. The Vendor shall provide the facility with the most current Food and Drug Administration (FDA) approved reagents necessary for the testing of blood and blood components. All requirements and provisions defined in the specification of this solicitation will apply to any vendor, i.e., branch, division, sub-Vendor, etc. supplying parts or reagents on behalf of the Vendor. For reagents with hazardous constituents, vendor shall provide a mechanism for the Laboratory to meet local discharge requirements. The vendor shall supply information regarding any hazardous chemicals. LICENSING AND ACCREDITATION The Vendor shall have all licenses, permits, accreditation and certificates required by law and/or regulatory compliance. Personnel assigned by the Vendor to perform these services covered under this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. SECURITY This vendor requires no access to AVAHCS or any VA information system. The C&A requirements do not apply. A Security Accreditation Package is not required. Attachment A Estimated Annual Quantity Usage Item Code Description of Reagent Size of Reagent Estimated Minimum Annual Usage Anti- A 10 ml X 10 1 Anti- B 10 ml X 10 1 Anti-D 10 ml X 10 1 Gamma Clone Control 10 ml X 10 1 Reagent RBC (Ref) A1 & B 10 ml X 2 26 Reagent RBC (Ref) A2 10 ml X 1 13 Panel Cells (1-16) 3 ml X 16 13 Gamma N-Hance 10 ml X 10 6 Anti-IgG 10 ml X 1 3 Anti- IgG C3 d 10 ml X 1 5 CorQC Test System 11.5 ml X 2 26 Check Cell-IgG coated pooled RBC 10 ml X 1 52 Gamma PEG 3 ml X 10 1 Panoscreen I, II, III 10 ml X 3 26 Bovine Albumin, 22% 10 ml X 10 1 Complement Control Cells 3 ml X 1 13 Anti- A1 (Lectin) 5 ml X 1 1 Anti- C (big C) Gammaclone 5 ml X 1 1 Anti-c (little c) Mono Ser 5 ml X 1 1 Anti-CW (anti rh) 2ml X 1 1 Anti-E Monoclonal (big E) Gammaclone 5 ml X 1 2 Anti-e Monoclonal Blend (little e) Gammaclone 5 ml X 1 1 Anti-Fy a (little a) Gamma Clone 5 ml X 1 1 Anti-Fy b (little b) 5 ml X 1 1 Anti- Jk a 5 ml X 1 1 Anti-Jk b 5 ml X 1 1 Anti-K Mono 5 ml X 1 1 Anti-k 5 ml X 1 1 Anti-Kp a 2 ml X 1 1 Anti-Kp b 2 ml X 1 1 Anti-Le a 5 ml X 1 2 Anti-Le b 5 ml X 1 1 Anti-N 5 ml X 1 1 Anti-M 5 ml X 1 1 Anti-P1 5 ml X 1 1 Anti-S 5 ml X 1 1 Anti-s Gamma clone 5 ml X 1 1 Anti- C3b C3d 5 ml X 1 8 Anti-JKA Gamma-clone 5ml X 1 1 Anti-JKB Gamma-clone 5ml X 1 1 Anti-S Gamma clone 5 ml X 1 1 Anti-Fy a (little a) 5 ml X 1 1 Anticipated Period of Performance: October 1, 2023, through September 30, 2028. The proposed sole source procurement will be made by a BPA contract with Immucor, Inc. The requesting activity has submitted a sole source justification request that states that vendor Immucor, Inc. is the only vendor that can provide the necessary required supplies and services. Market research did not find an alternate approved vendor that can provide the required supplies and services. This notice is not to be considered a request for quotations or proposals. No contract will be awarded on the basis of offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the Government. If no affirmative written response is received within five (5) business days from the publication of this notice, a contract will be issued to Immucor, Inc. without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is FAR 8.405-6(a)(1)(B), Only One Source is Capable of Providing the Supplies or Services Required at the Level of Quality Because the Supplies or Services are Unique or Highly Specialized.
